Четвертое универсальное определение инфаркта миокарда (2018)
 Скачать 1.92 Mb.
|
|
Словения: Словенское общество кардиологов, Питер Радсель; Испания: испанское общество кардиологов, Алессандро Сионис; Швеция: Шведское общество кардиологов, Томас Джемберг; Швейцария: Швейцарское общество кардиологов, Кристиан Мюллер; Тунис: Тунисское общество кардиологов и сердечно-сосудистой хирургии, Лейла Абид; Турция: турецкое общество кардиологов, Аднан Абачи; Украина: Украинская ассоциация кардиологов, Александр Пархоменко; Соединенное Королевство: Британское сердечно-сосудистое общество, Саймон Корбетт. Утверждено Комитетом одобрения клинической политики ACC. Утверждено Научным консультативным и координационным комитетом AHA. CV всех экспертов, участвовавших в разработке этого Экспертного консенсуса, можно найти на веб-сайте ESC. www.escardio.org/guidelines Содержание этого экспертного консенсусного документа ESC / ACC / AHA / WHF публикуется только для личного и образовательного использования. Коммерческое использование не разрешено. Никакая часть экспертного консенсуса ESC / ACC / AHA / WHF не может быть переведена или воспроизведена в любой форме без письменного разрешения ESC или ACC или AHA или WHF. Разрешение может быть получено после подачи письменного запроса в издательство Оксфордского университета, издателя Европейского журнала сердца и группы, уполномоченной обрабатывать такие разрешения от имени ESC, ACC, AHA и WHF ( journalals.permissions@oxfordjournals.org ). Отказ от ответственности. В документе ESC/ACC/AHA/WHF «Экспертный консенсус» представлены мнения ESC, ACC, AHA и WHF, которые были подготовлены после тщательного изучения научных и медицинских данных и доказательств, имеющихся на момент их публикации. ESC, ACC, AHA и WHF не несут ответственности в случае каких-либо противо- речий, несоответствий и/или двусмысленности между Экспертным соглашением ESC/ACC/ AHA/WHF и любыми другими официальными рекомендациями или Экспертным соглашением, выданным соответствующими органов общественного здравоохранения, в частности в отношении эффективного использования медицинских или терапевтических стратегий. Спе- циалистам в области здравоохранения рекомендуется полностью учитывать Экспертный консенсус ESC / ACC / AHA / WHF при осуществлении их клинических оценок, а также в ЭКСПЕРТНЫЙ КОНСЕНСУСНЫЙ ДОКУМЕНТ 45 определении и осуществлении профилактических, диагностических или терапевтических ме- дицинских стратегий; однако в документе экспертным документом ESC / ACC / AHA / WHF никоим образом не отменяется индивидуальная ответственность медицинских работников за принятие правильных и точных решений с учетом состояния здоровья каждого пациента и в консультации с этим пациентом или соответствующим и/или необходимым, опекуном пациента. Кроме того, экспертный консенсус ESC / ACC / AHA / WHF не предоставляет специалистам здравоохранения полное и тщательное рассмотрение соответствующих офици- альных обновленных рекомендаций или экспертных консенсусных документов, выданных компетентными органами общественного здравоохранения, для того чтобы заниматься каждым конкретным пациентом в свете научно принятых данных в соответствии с их этическими и профессиональными обязательствами. Также ответственность медицинского работника заключается в проверке применимых правил и положений, касающихся лекарств и медицинских устройств, во время применения. 43. Благодарности Мы благодарны Карен А. Хикс за ценные советы. ЭКСПЕРТНЫЙ КОНСЕНСУСНЫЙ ДОКУМЕНТ 46 44. Ссылки: 1 Hammer A. Ein Fall von thrombotischem Verschlusse einer der Kranzarterien des Herzens. Wien Med Wschr 1878;28:97–102. 2 Obraztzow VP, Straschesko ND. Zur Kenntnis der Thrombose der Koronararterien des Herzens. Z Klin Med 1910;71:116–132. 3 Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA 1912;59:2015–2022. 4 Friedberg CK, Horn H. Acute myocardial infarction not due to coronary artery occlusion. JAMA 1939;112:1675–1679. 5 World Health Organization. Working Group on the Establishment of Ischemic Heart Disease Registers. Report of the Fifth Working Group, Copenhagen. In: Report No. Eur 8201 (5 ). Geneva: World Health Organization; 1971. 6 Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979;59:607–609. 7 Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583–612. 8 Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D, Goldberg RJ, Hand MM, Jaffe AS, Julian DG, Levy D, Manolio T, Mendis S, Mensah G, Pajak A, Prineas RJ, Reddy KS, Roger VL, Rosamond WD, Shahar E, Sharrett AR, Sorlie P, Tunstall-Pedoe H. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003;108:2543–2549. 9 The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000;21:1502–1513; J Am Coll Cardiol 2000;36:959–969. 10 Thygesen K, Alpert JS, White HD; Joint ESC/ACC/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525–2538; Circulation 2007;116:2634–2653; J Am Coll Cardiol 2007;50:2173– 2195. 11 Mendis S, Thygesen K, Kuulasmaa K, Giampaoli S, Mähönen M, Ngu Blackett K, Lisheng L; Writing group on behalf of the participating experts of the WHO consultation for revision of WHO definition of myocardial infarction. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 2011;40:139–146. 12 Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Writing Group on the Joint ESC/ACC/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551– 2567; Circulation 2012;126:2020–2035; J Am Coll Cardiol 2012;60:1581–1598. 13 Sarkisian L, Saaby L, Poulsen TS, Gerke O, Jangaard N, Hosbond S, Diederichsen ACP, Thygesen K, Mickley H. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am J Med 2016;129:446e.5– 446e.21. 14 Sarkisian L, Saaby L, Poulsen TS, Gerke O, Hosbond S, Jangaard N, Diederichsen ACP, Thygesen K, Mickley H. Prognostic impact of myocardial injury related to various cardiac and noncardiac conditions. Am J Med 2016;129:506–514. ЭКСПЕРТНЫЙ КОНСЕНСУСНЫЙ ДОКУМЕНТ 47 15 Ooi DS, Isotalo PA, Veinot JP. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Clin Chem 2000;46:338–344. 16 Jennings RB, Ganote CE. Structural changes in myocardium during acute ischemia. Circ Res 1974;35:156–172. 17 Virmani R, Forman MB, Kolodgie FD. Myocardial reperfusion injury. Histopathological effects of perfluorochemical. Circulation 1990;81:IV57–IV68. 18 Reimer KA, Jennings RB, Tatum AH. Pathobiology of acute myocardial ischemia: Metabolic, functional and ultrastructural studies. Am J Cardiol 1983;52:72A–81A. 19 Ibáñez B, Heusch G, Ovize M, Van de Werf F. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol 2015;65:1454–1471. 20 Montecucco F, Carbone F, Schindler TH. Pathophysiology of ST-segment elevation myocardial infarction: Novel mechanisms and treatments. Eur Heart J 2016;37:1268–1283. 21 Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, Lindahl B, Giannitsis E, Hasin Y, Galvani M, Tubaro M, Alpert JS, Biasucci LM, Koenig W, Mueller CH, Huber K, Hamm C, Jaffe AS; The Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010;31:2197–2204. 22 Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, Huber K, Plebani M, Biasucci LM., Tubaro M, Collinson P, Venge P, Hasin Y, Galvani M, Koenig W, Hamm C, Alpert JS, Katus H, Jaffe AS; Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012;33:2252–2257. 23 Rittoo D, Jones A, Lecky B, Neithercut D. Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: Implications for the diagnosis of myocardial infarction. J Am Coll Cardiol 2014;63:2411–2420. 24 Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS. Diseased skeletal muscle: A noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol 2011;58:1819–1824. 25 Wens SCA, Schaaf GJ, Michels M, Kruijshaar ME, van Gestel TJM, In ‘t Groen S, Pijnenburg J, Dekkers DHW, Demmers JAA, Verdijk LB, Brusse E, van Schaik RHN, van der Ploeg AT, van Doorn PA, Pijnappel WWMP. Elevated plasma cardiac troponin T levels caused by skeletal muscle damage in Pompe disease. Circ Cardiovasc Genet 2016;9:6–13. 26 Mair J, Lindahl B, Müller C, Giannitsis E, Huber K, Möckel M, Plebani M, Thygesen K, Jaffe AS. What to do when you question cardiac troponin values. Eur Heart J Acute Cardiovasc Care ; doi: 10.1177/2048872617708973. Published online ahead of print 1 May 2017. 27 Mair J, Lindahl B, Hammarsten O, Müller C, Giannitsis E, Huber K, Möckel M, Plebani M, Thygesen K, Jaffe AS; European Society of Cardiology (ESC) Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association (ACCA). How is cardiac troponin released from injured myocardium? Eur Heart J Acute Cardiovasc Care ; doi: 10.1177/2048872617748553. Published ahead of print 1 December 2017. 28 Vestergaard KR, Jespersen CB, Arnadottir A, Soletormos G, Schou M, Steffensen R, Goetze JP, Kjoller E, Iversen KK. Prevalence and significance of troponin elevations in patients without acute coronary disease. Int J Cardiol 2016;222:819–825. 29 Schmid J, Liesinger L, Birner-Gruenberger R, Stojakovic T, Scharnagl H, Dieplinger B, Asslaber M, Radl R, Beer M, Polacin M, Mair J, Szolar D, Berghold A, Quasthoff S, Binder JS. Rainer PP. Elevated cardiac troponin T in skeletal myopathies. J Am Cardiol Coll 2018;71:1540–1549. 30 Apple FS, Jaffe AS, Collinson P, Mockel M, Ordonez-Llanos J, Lindahl B, Hollander J, Plebani M, Than M, Chan MH; on behalf of the International Federation of Clinical Chemistry (IFCC) Task Force on Clinical Applications of Cardiac Bio-Markers. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem 2015;48:201–203. ЭКСПЕРТНЫЙ КОНСЕНСУСНЫЙ ДОКУМЕНТ 48 31 Goodman SG, Steg PG, Eagle KA, Fox KA, López-Sendón J, Montalescot G, Budaj A, Kennelly BM, Gore JM, Allegrone J, Granger CB, Gurfinkel EP; GRACE Investigators. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: Lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2006;151:654– 660. 32 Weil BR, Suzuki G, Young RF, Iyer V, Canty JMJr. Troponin release and reversible left ventricular dysfunction following transient pressure overload: Stress-induced myocardial stunning. J Am Cardiol Coll 2018;71:2906–2916. 33 Turer AT, Addo TA, Martin JL, Sabatine MS, Lewis GD, Gerszten RE, Keeley EC, Cigarroa JE, Lange RA, Hillis LD, de Lemos JA. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: Insights from a coronary sinus sampling study. J Am Coll Cardiol 2011;57:2398–2405. 34 Siriwardena M, Campbell V, Richards AM, Pemberton CJ. Cardiac biomarker responses to dobutamine stress echocardiography in healthy volunteers and patients with coronary artery disease. Clin Chem 2012;58:1492–1494. 35 White HD. Pathobiology of troponin elevations: Do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol 2011;57:2406–2408. 36 Jaffe AS, Wu AH. Troponin release—reversible or irreversible injury? Should we care? Clin Chem 2012;58:148–150. 37 Eggers KM, Lindahl B. Application of cardiac troponin in cardiovascular diseases other than acute coronary syndrome. Clin Chem 2017;63:223–235. 38 Giannitsis E, Katus HA. Cardiac troponin level elevations not related to acute coronary syndromes. Nat Rev Cardiol 2013;10:623–634. 39 Agewall S, Giannitsis E, Jernberg T, Katus H. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J 2011;32:404–411. 40 Kelley WE, Januzzi JL, Christenson RH. Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 2009;55:2098–2112. 41 Jeremias A, Gibson CM. Alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 2005;142:786–791. 42 Weil BR, Young RF, Shen X, Suzuki G, Qu J, Malhotra S, Canty JM Jr. Brief myocardial ischemia produces cardiac troponin I release and focal myocyte apoptosis in the absence of pathological infarction in swine. JACC Basic Transl Sci 2017;2:105–114. 43 Braunwald E, Morrow DA. Unstable angina: Is it time for a requiem? Circulation 2013;127:2452–2457. 44 Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res 2014;114:1852–1866. 45 Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: The pathologists’ view. Eur Heart J 2013;34:719–728. 46 Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2018;39:119–177. 47 Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, da Mehilli J, Mukherjee D, Storey RF, Windecker S. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2016;37:267–315. 48 Saaby L, Poulsen TS, Hosbond S, Larsen TB, Pyndt Diederichsen AC, Hallas J, Thygesen K, Mickley H. Classification of myocardial infarction: Frequency and features of type 2 myocardial infarction. Am J Med 2013;126:789–797. ЭКСПЕРТНЫЙ КОНСЕНСУСНЫЙ ДОКУМЕНТ 49 49 Cediel G, Gonzalez-del-Hoyo M, Carrasquer A, Sanchez R, Boqué C, Bardají A. Outcomes with type 2 myocardial infarction compared with non-ischemic myocardial injury. Heart 2017;103:616–622. 50 Baron T, Hambraeus K, Sundström J, Erlinge D, Jernberg T, Lindahl B; TOTAL-AMI study group. Type 2 myocardial infarction in clinical practice. Heart 2015;101:101–106. 51 Shah AS, McAllister DA, Mills R, Lee KK, Churchhouse AM, Fleming KM, Layden E, Anand A, Fersia O, Joshi NV, Walker S, Jaffe AS, Fox KA, Newby DE, Mills NL. Sensitive troponin assay and the classification of myocardial infarction. Am J Med 2015;128:493–501. 52 Gupta S, Vaidya SR, Arora S, Bahekar A, Devarapally SR. Type 2 versus type 1 myocardial infarction: A comparison of clinical characteristics and outcomes with a meta-analysis of observational studies. Cardiovasc Diagn Ther 2017;7:348–358. 53 Sandoval Y, Thygesen K. Myocardial infarction type 2 and myocardial injury. Clin Chem 2017;63:101–107. 54 Saaby L, Poulsen TS, Diederichsen ACP, Hosbond S, Larsen TB, Schmidt H, Gerke O, Hallas J, Thygesen K, Mickley H. Mortality rate in type 2 myocardial infarction: Observations from an unselected hospital cohort. Am J Med 2014;127:295–302. 55 Lambrecht S, Sarkisian L, Saaby L, Poulsen TS, Gerke O, Hosbond S, Diederichsen ACP, Thygesen K, Mickley H. Different causes of death in patients with myocardial infarction type 1, type 2 and myocardial injury. Am J Med 2018;131:548–554. 56 Chapman AR, Shah ASV, Lee KK, Anand A, Francis O, Adamson P, McAllister DA, Strachan F, Newby DE, Mills NL. Long term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation 2018;137:1236–1245. 57 Neumann JT, Sörensen NA, Rübsamen N, Ojeda F, Renne T, Qaderi V, Teltrop E, Kramer S, Quantius L, Zeller T, Karakas M, Blankenberg S, Westermann D. Discrimination of patients with type 2 myocardial infarction. Eur Heart J 2017; 38:3514–3520. 58 Saw J, Mancini GB, Humphries KH. Contemporary review on spontaneous coronary artery dissection. J Am Coll Cardiol 2016;68:297–312. 59 Januzzi JL, Sandoval Y. The many faces of type 2 myocardial infarction. J Am Cardiol Coll 2017;70:1569–1572. 60 Jangaard N, Sarkisian L, Saaby L, Mikkelsen S, Lassen AM, Marcussen N, Thomsen JL, Diederichsen A, Thygesen K, Mickley H. Incidence, frequency and clinical characteristics of type 3 myocardial infarction in clinical practice. Am J Med 2017;130:862.e9–862.e14. 61 Selvanayagam JB, Petersen SE, Francis JM, Robson MD, Kardos A, Neubauer S, Taggart DP. Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: A randomized trial using cardiovascular magnetic resonance imaging and biochemical markers. Circulation 2004;109:345–350. 62 Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, Banning AP. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: Insights from cardiovascular magnetic resonance imaging. Circulation 2005;111:1027–1032. 63 Rahimi K, Banning AP, Cheng AS, Pegg TJ, Karamitsos TD, Channon KM, Darby S, Taggart DP, Neubauer S, Selvanayagam JB. Prognostic value of coronary revascularisation-related myocardial injury: A cardiac magnetic resonance imaging study. Heart 2009;95:1937–1943. 64 Tricoci P. Consensus or controversy?: Evolution of criteria for myocardial infarction after percutaneous coronary intervention. Clin Chem 2017;63:82–90. 65 Ndrepepa G, Colleran R, Braun S, Cassese S, Hieber J, Fusaro M, Kufner S, Ott I, Byrne RA, Husser O, Hengstenberg C, Laugwitz KL, Schunkert H, Kastrati A. High-sensitivity troponin T and mortality after elective percutaneous coronary intervention. J Am Coll Cardiol 2016;68:2259–2268. 66 Zeitouni M, Silvain J, Guedeney P, Kerneis M, Yan Y, Overtchouk P, Barthelemy O, Hauguel- Moreau M, Choussat R, Helft G, Le Feuvre C, Collet JP, Montalescot G; ACTION Study |